• Skip to main content
  • Skip to footer

Amicus

  • Home
  • About Fabry
    • Fabry disease pathophysiology and natural history
    • Prevalence of Fabry disease
    • GLA gene mutations and inheritance
    • Clinical manifestations of Fabry disease
    • Diagnosis of Fabry disease
    • Management of Fabry disease
  • About Pompe
    • Pompe disease pathophysiology and natural history
    • Prevalence of Pompe disease
    • GAA gene mutations and inheritance
    • Clinical manifestations of Pompe disease
    • Diagnosis of Pompe disease
    • Management of Pompe disease
  • Your Specialty
    • Nephrology
      • Renal pathophysiology in Fabry disease
      • When should a nephrologist suspect Fabry disease
      • Management of Fabry disease
    • Cardiology
      • Cardiac pathophysiology in Fabry disease
      • When should a cardiologist suspect Fabry disease
      • Management of Fabry disease
    • Neuropsychology and ophthalmology
      • Pathophysiology and progression in Fabry disease
      • Neurology and Fabry disease
      • Psychology and Fabry disease
      • Ophthalmology and Fabry disease
      • When should you suspect Fabry disease?
      • Management of Fabry disease
    • Respiratory
      • Respiratory pathophysiology in Pompe disease
      • When should a respiratory specialist suspect Pompe disease?
      • Management of Pompe disease
    • Neurology
      • Pathophysiology of muscle damage
      • When should a neurologist suspect Pompe disease?  
      • Management of Pompe disease
  • Resources
    • All Resources
    • Latest Blog
  • Find a specialist centre

When should a neurologist suspect Pompe disease?  

Neurology

When should a neurologist suspect Pompe disease? 

The information on this page is tailored for neurologists. For more detailed information on the cause, inheritance, diagnosis and management of Pompe disease, please refer to our ‘About Pompe disease’ page.

Learn more

Neuromuscular signs in Pompe disease

In late-onset Pompe disease, the first clinical manifestations are often proximal muscle weakness accompanied by other nonspecific complaints of exercise intolerance, muscle pain and fatigue. Tongue weakness is often an early sign, which can cause swallowing and speaking difficulties when coupled with bulbar muscle impairment.1,2 Progressive muscle deterioration leads to problems with activities of daily living, significant motor impairment, reduced mobility and eventual wheelchair use.2

These early manifestations mean awareness of late-onset Pompe disease by neurologists may be key in establishing the correct diagnosis. Neuromuscular evaluations – namely functional testing and electromyography – can help raise suspicion.2,3

Click on the headings to find out about these examinations and the findings suggestive of late-onset Pompe disease.

  • Manual or quantitative muscle testing (QMT)
  • Pattern of weakness is suggestive of late-onset Pompe disease
  • Proximal weakness greater than distal
  • Increased membrane irritability
  • Myotonic discharges (typical or atypical, may be observed only in the paraspinal muscles)
  • Short duration and low amplitude motor unit action potentials (MUAPs)

Laboratory testing often reveals elevated creatine kinase levels (hyperCKaemia) early in the disease course, with levels ranging from normal to 15 times the upper limit of normal. As a result, any of the following should raise suspicion of late-onset Pompe disease:2

  • Unexplained proximal/axial muscle weakness (with or without respiratory symptoms)
  • Restrictive respiratory insufficiency with hyperCKaemia (up to 15-fold)
  • Exercise intolerance

Differential diagnoses of Pompe disease

Electrophysiological studies are also useful to consider potential differential diagnoses, especially since the initial nonspecific symptoms of late-onset Pompe disease can clinically resemble a range of other neuromuscular disorders, as shown in the table below.2,4

Differential diagnosisShared signs/symptoms
Limb–girdle muscular dystrophyProgressive muscle weakness in the pelvis, legs, and shoulders; elevated CK
Becker muscular dystrophyProgressive proximal muscle weakness, prominent quadriceps weakness, calf hypertrophy, elevated CK
Myasthenia gravisProximal muscle weakness
Spinal muscular atrophyProgressive proximal muscle weakness and atrophy, mild elevated CK
PolymyositisUnexplained muscle weakness with elevated CK
Glycogen storage diseases (IIIa, IV, V)Hypotonia, muscle weakness with distal involvement, elevated CK
Danon diseaseSkeletal muscle myopathy
Mitochondrial myopathiesHypotonia, muscle weakness, elevated CK
Lipid storage myopathiesFluctuating muscle weakness, elevated CK
Selenoprotein N1-related myopathyMuscle hypotrophy
CK: creatine kinase.
Adapted from Ozdamar et al., 2023.2

Other signs and symptoms of Pompe disease

Given Pompe disease is a rare disorder with a wide clinical spectrum, nonspecific initial symptoms and a variable disease course, neurologists need a high index of suspicion to recognise late-onset Pompe disease in clinical practice.2 It is important to be aware of some of the key non-neurological manifestations, including:1

Musculoskeletal

Scapular winging, osteopenia/osteoporosis, vertebral fractures, rigid/bent spine syndromes, scoliosis /kyphosis/hyperlordosis

Respiratory

Headaches, sleepiness, sleep apnoea, shortness of breath, impaired cough, respiratory failure

Gastrointestinal

Chronic diarrhoea, vomiting, abdominal pain, lack of appetite, early satiety and bowel incontinence

Cerebrovascular

Aneurysm formation, haemorrhage, stroke, vascular, stiffness leading to increased blood pressure

Cardiac

Rhythm disturbances, cardiac hypertrophy

Nervous system

Paraesthesia, burning feet

Please refer to the ‘About Pompe’ page for further information on the signs and symptoms of Pompe disease.

If you suspect Pompe disease, referral to nominated ultra-specialist centre is essential so that patients can access full genetic testing and access to disease-specific therapies. Please refer to our ‘Find a specialist centre’ page to find out more.

Learn more

NP-NN-GB-00031223
October 2024

  1. Toscano A, Rodolico C, Musumeci O. Multisystem late onset Pompe disease (LOPD): an update on clinical aspects. Ann Transl Med. 2019;7(13):284.
  2. Ozdamar SE, Koc AF, Durmus Tekce H, et al. Expert opinion on the diagnostic odyssey and management of late-onset Pompe disease: a neurologist’s perspective. Front Neurol. 2023;14:1095134.
  3. American Association of Neuromuscular & Electrodiagnostic Medicine. Diagnostic criteria for late-onset (childhood and adult) Pompe disease. Muscle Nerve. 2009;40(1):149-160.
  4. Musumeci O, Toscano A. Diagnostic tools in late onset Pompe disease (LOPD). Ann Transl Med. 2019;7(13):286.

1.
Pathophysiology of muscle damage

3.
Management of Pompe disease

This non-promotional website is intended for UK Healthcare Professionals only.

Footer

Amicus is committed to providing medical education for UK healthcare professionals. This website is a non-promotional site developed and funded by Amicus.

Menu
Home
About Fabry
About Pompe
Nephrology
Cardiology
Neuropsychology and Ophthalmology
Respiratory
Neurology
Resources
Find a Specialist Centre

Company
About Amicus

Help
Contact us

© Amicus Education 2024. All rights reserved | Amicus therapeutics UK LTD One Globeside, Fieldhouse Lane, Marlow SL7 7HZ United Kingdom | Company registration no. 05541527 | NP-NN-UKI-00090325 March 2025 Privacy policy | Cookie policy | Terms of use